MEDCAP AB SK-40
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium… Read more
Market Cap & Net Worth: MEDCAP AB SK-40 (61MA)
MEDCAP AB SK-40 (F:61MA) has a market capitalization of $672.17 Million (€654.83 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #9964 globally and #1062 in its home market, demonstrating a -3.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDCAP AB SK-40's stock price €43.60 by its total outstanding shares 15019141 (15.02 Million).
MEDCAP AB SK-40 Market Cap History: 2020 to 2026
MEDCAP AB SK-40's market capitalization history from 2020 to 2026. Data shows growth from $336.86 Million to $672.17 Million (23.59% CAGR).
MEDCAP AB SK-40 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDCAP AB SK-40's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 61MA by Market Capitalization
Companies near MEDCAP AB SK-40 in the global market cap rankings as of March 18, 2026.
Key companies related to MEDCAP AB SK-40 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
MEDCAP AB SK-40 Historical Marketcap From 2020 to 2026
Between 2020 and today, MEDCAP AB SK-40's market cap moved from $336.86 Million to $ 672.17 Million, with a yearly change of 23.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €672.17 Million | -13.66% |
| 2025 | €778.55 Million | -2.70% |
| 2024 | €800.13 Million | +69.33% |
| 2023 | €472.52 Million | +59.47% |
| 2022 | €296.31 Million | +12.40% |
| 2021 | €263.63 Million | -21.74% |
| 2020 | €336.86 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of MEDCAP AB SK-40 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $672.17 Million USD |
| MoneyControl | $672.17 Million USD |
| MarketWatch | $672.17 Million USD |
| marketcap.company | $672.17 Million USD |
| Reuters | $672.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.